 Anixa Biosciences, Inc. NASDAQ: ANIX, a biotechnology company focused on harnessing the bodys immune system in the fight against cancer, today announced an update regarding the chimeric antigen receptor T-cell CAR-T technology it is developing with its partner, Moffitt Cancer Center. 